| |
| |
|
| Insider
Information: |
Milligan John F |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,574,306 |
|
|
Indirect Shares
|
211,755 |
|
|
| Direct
Value |
$101,180,647 |
|
|
|
Indirect Value
|
$7,182,494 |
|
|
| Total
Shares |
1,786,061 |
|
|
| Total
Value |
$108,363,140 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
President and CEO, Dir... |
2018-11-27 |
1,574,306 |
2012-01-06 |
111,755 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-15 |
0 |
2020-12-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
159 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2008-12-01 |
4/A |
S |
$43.73 |
$2,623,800 |
D/D |
(60,000) |
222,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2008-12-19 |
4 |
OE |
$3.70 |
$80,548 |
D/D |
20,000 |
242,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-03-02 |
4 |
OE |
$8.22 |
$493,128 |
D/D |
60,000 |
302,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-03-02 |
4 |
S |
$44.42 |
$2,665,014 |
D/D |
(60,000) |
242,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-03-12 |
4 |
D |
$44.04 |
$282,120 |
D/D |
(6,406) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
256,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-05 |
4 |
OE |
$8.94 |
$1,780,380 |
D/D |
199,092 |
448,967 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-05 |
4 |
S |
$44.49 |
$8,857,723 |
D/D |
(199,092) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-06 |
4 |
S |
$44.09 |
$4,508,043 |
D/D |
(102,248) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-06 |
4 |
OE |
$8.94 |
$914,353 |
D/D |
102,248 |
352,123 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-07 |
4 |
S |
$44.45 |
$3,880,546 |
D/D |
(87,300) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-07 |
4 |
OE |
$8.94 |
$780,680 |
D/D |
87,300 |
337,175 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-06-01 |
4 |
S |
$42.83 |
$2,571,336 |
D/D |
(60,000) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-06-01 |
4 |
OE |
$8.22 |
$493,128 |
D/D |
60,000 |
309,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-09-01 |
4 |
S |
$45.46 |
$2,727,672 |
D/D |
(60,000) |
250,354 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-09-01 |
4 |
OE |
$8.22 |
$493,128 |
D/D |
60,000 |
310,354 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-12-01 |
4 |
OE |
$8.22 |
$493,128 |
D/D |
60,000 |
310,354 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-12-01 |
4 |
S |
$46.03 |
$2,761,542 |
D/D |
(60,000) |
250,354 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-12-24 |
4 |
OE |
$3.70 |
$80,050 |
D/D |
17,748 |
268,102 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2010-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
296,102 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2010-12-20 |
4 |
OE |
$0.00 |
$0 |
I/I |
7,352 |
111,755 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
214,776 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4 |
D |
$39.79 |
$417,477 |
D/D |
(10,492) |
204,284 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
27,000 |
219,276 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2011-03-15 |
4/A |
D |
$39.79 |
$501,434 |
D/D |
(12,602) |
206,674 |
0 |
- |
|
159 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
